Quantum Pharma acquires Lamda companies
Quantum Pharma is pleased to announce the acquisition of Lamda (UK) Limited, Lamda Laboratories SA and Lamda Pharmaceuticals SA. Lamda is a pharmaceutical development and licensing business with customers in the UK, Germany, Italy, Scandinavia and Greece. Lamda provides a fully outsourced research and development service to companies looking to license medicinal products from its state of the art development laboratories near Athens, Greece.
Lamda significantly increases the Group’s current product development portfolio by both number of products and therapeutic area.
Andrew Scaife, Chief Executive Officer of Quantum Pharma Plc, said: “The acquisition of Lamda represents an important and exciting milestone for the Group. The addition of Lamda to the Group provides us with a significantly enlarged product portfolio and in-house development capability. It gives the Group even more control over speed of delivery whilst maintaining our high standards of customer service. Lamda also gives us a footprint in Europe which we can use as a platform for overseas expansion.”
Posted by: Quantum Webmaster on 17th April 2015